MedTrace Logo

Ginkgo Biloba vs Desmopressin in Treatment of Children With Monosymptomatic Nocturnal Enuresis

NCT06771128 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 398

Last updated 2026-01-13

No results posted yet for this study

Summary

the efficacy of Ginkgo Biloba versus desmopressin in treatment of children with monosymptomatic nocturnal enuresis

Conditions

  • Nocturnal Enuresis in Children
  • Desmopressin
  • Monosymptomatic Nocturnal Enuresis

Interventions

DRUG

Desmopressin like Placebo

patients receive Desmopressin like Placebo oral tablet once daily

DRUG

Ginkgo Biloba oral tablet

patients receive Ginkgo Biloba oral tablet 120 mg once daily

DRUG

Desmopressin Acetate 0.2 mg Tablets

patient receives desmopressin 0.2 mg oral tablet once daily

DRUG

Ginkgo Biloba like Placebo

patients receive Ginkgo Biloba like Placebo oral tablet once daily

Sponsors & Collaborators

  • Menoufia University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
5 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-01
Primary Completion
2025-12-01
Completion
2026-01-01

Countries

  • Egypt

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06771128 on ClinicalTrials.gov